September 21, 2021
Hemab Appoints Mads Behrndt as Chief Financial Officer
Media
September 20, 2021
Aprea Therapeutics Presents Data From Phase 1/2 Trial of Eprenetapopt (APR-246) in Advanced Solid Tumors at ESMO Congress 2021
September 17, 2021
Vicore starts dosing of first COVID-19 patients in the global phase 3 trial ATTRACT-3
September 16, 2021
Targovax ASA: Poster at European Society for Medical Oncology (ESMO)
September 14, 2021
Nordic Nanovector Appoints Experienced Pharmaceutical Business Leader Erik Skullerud as Chief Executive Officer
September 14, 2021
Aprea Therapeutics to Present Data from Phase 1/2 Trial of Eprenetapopt in Advanced Solid Tumors at ESMO Congress 2021
September 13, 2021
Precirix and IFE sign clinical trial manufacturing agreement
September 11, 2021
Oncopeptides presents phase 3 OCEAN study results at the IMW meeting
September 09, 2021
Study results on FORTIFY are inconclusive
September 09, 2021
Webcast for presentation of OCEAN data presented at IMW
